SXTC - רווח נקי למניה (EPS TTM) SXT Pharmaceuticals

China SXT Pharmaceuticals (SXTC) seeks to monetize conservative demand for traditional herbal formulations. The trailing 12-month earnings per share visualizes the progress toward this goal, where -65048.67 reflects the metric's latest value. However, the modernization of standards in collaboration with institutions and the unstable management of the micro-cap business create significant obstacles to the implementation of the long-term commercial development plan.
SXTC (SXT China): פילוחים אנליטיים ודוחות לפי אינדיקטורים

This indicator is calculated as the ratio of net income to the weighted average number of shares, which isolates actual earnings from the impact of share issuances or buybacks. Given the strict government regulation of the TCM market and the patent protection of China SXT Pharmaceuticals (SXTC), the rolling earnings per share figure reflects the efficiency of monetizing exclusive raw material extraction rights on a per-share basis.